Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06310304
Status:
COMPLETED
Last Update Posted:
2024-06-05
First Post:
2024-03-07
Brief Title:
A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release XR Tablets Compared With Ruxolitinib Immediate Release IR Tablets Administered Orally in Healthy Participants
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Organization Data
Organization:
Incyte Corporation
Class:
INDUSTRY
Study ID:
INCB18424-153
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Incyte Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None